Thyroid-Stimulating Immunoglobulin (TSI)
An autoantibody that mimics TSH and switches the thyroid on continuously — the direct cause of Graves' disease.
The confirmatory test for Graves' disease, the most common cause of hyperthyroidism. Distinguishes it from thyroiditis and other causes, which are managed completely differently.
TSI is a cause test, not a status test, and ordering it in somebody with a normal TSH is asking a question that has no answer. Its two genuine uses are pinning the aetiology of thyrotoxicosis without needing a radioiodine uptake scan, and — the one people forget — assessing risk to a fetus in a pregnant woman with current or past Graves' disease, because these antibodies cross the placenta and can act on the fetal thyroid even after the mother has been treated. No titre is optimal; negative is simply negative.
What did your thyroid-stimulating immunoglobulin result show?
What to do next. Graves' is a medical diagnosis needing proper management, not a supplement problem. Two things matter from the Vault side: iodine and iodine-containing supplements such as kelp can make hyperthyroidism considerably worse, and ashwagandha raises thyroid hormone, which is the wrong direction here. Selenium has some evidence for the eye component.
What Thyroid-Stimulating Immunoglobulin (TSI) actually measures — the analyte, and the assay
Two tests share this page and they measure different things. A TSH receptor antibody (TRAb) binding assay measures whether antibodies attach to the receptor, whatever they then do. A thyroid-stimulating immunoglobulin bioassay measures whether they turn it on. Binding is necessary for stimulating and not sufficient, because blocking antibodies bind the same receptor and switch it off Yao 2024.
The bioassay is a cell experiment run on your serum. Cells engineered to express the human TSH receptor and a cyclic-AMP-responsive reporter are incubated with patient serum; if stimulating antibodies are present, cyclic AMP rises and the reporter lights up. The analytical performance and clinical utility of exactly this design have been characterized Leschik 2013.
The binding assay is competitive and much faster. Patient antibodies compete with a labeled monoclonal antibody or with TSH itself for the receptor, so the result is inhibition of binding — the original name, thyrotropin binding inhibitory immunoglobulin, describes the measurement honestly.
The two agree in most patients and diverge in the ones who matter. Head-to-head evaluation of diagnostic performance for Graves' disease shows overlapping but non-identical sensitivity, and the divergence is largest in blocking-antibody disease, in pregnancy and during antithyroid drug treatment Xu 2023 Yao 2024.
Thyroid-Stimulating Immunoglobulin (TSI): what changes the blood, and what only changes the reading
What changes the antibody in you:
- Graves' disease activity, which is the antibody's whole meaning — and its level carries prognostic information about relapse after antithyroid drug withdrawal Zhou 2021.
- Antithyroid drug treatment, under which titers fall over months in patients heading for remission and do not in those who will relapse Zhou 2021.
- Radioiodine, which characteristically raises TRAb for 6 to 12 months by releasing antigen — a rise after treatment is expected and is not treatment failure.
- Thyroidectomy, after which levels usually fall slowly over years.
- Pregnancy and the postpartum period, across which titers fall then rebound; the third-trimester value is the one that predicts neonatal thyrotoxicosis because IgG crosses the placenta Yao 2024.
- Hashimoto's thyroiditis, in which blocking antibodies can appear — and a binding assay cannot tell them from stimulating ones Xu 2023.
What changes only the reading:
- Whether the laboratory ran a bioassay or a binding assay, and the report often does not make it obvious Yao 2024.
- Which generation of binding assay. First-, second- and third-generation TRAb assays use different competitors and different units, and their cut-offs are not interchangeable Lorde 2023.
- Units. Bioassay results are reported as a stimulation index or percent of a reference; binding assays in IU/L. These are not convertible.
- Biotin, which interferes with several thyroid immunoassays and is one of the recognized causes of a discordant thyroid panel Al-Bahadili 2024 Li 2020.
- Heterophile antibodies, the standard sandwich-assay failure Ghazal 2022.
Reference interval or decision threshold — which kind of number Thyroid-Stimulating Immunoglobulin (TSI) is
The cut-off is a diagnostic decision threshold, chosen against a clinical diagnosis of Graves' disease. It was set to separate patients from controls, which makes it a performance choice: move the line and you trade sensitivity for specificity Xu 2023.
It is method-specific and generation-specific. A value of 2.0 means nothing without the assay that produced it, and a laboratory change mid-course invalidates the series Lorde 2023.
The prognostic use has its own thresholds, and they are different. The level that predicts relapse after antithyroid drug withdrawal is not the level that diagnoses the disease Zhou 2021.
The pregnancy threshold is different again and is an obstetric one. A titer several times the upper reference limit in the third trimester is what triggers fetal surveillance, and it is a consensus figure rather than an outcome-derived one Yao 2024.
How you would know your Thyroid-Stimulating Immunoglobulin (TSI) was wrong — and when to redraw
Three to six months, and the clock is IgG's. Immunoglobulin G has a serum half-life of about 21 days, so a real change in antibody production takes 2 to 3 months to show fully. A repeat at 4 weeks is measuring the assay.
After radioiodine, wait 12 months before interpreting a rise. The post-treatment increase is antigen release, not worsening disease.
Conditions that must match: the same assay type and generation, named on the report Lorde 2023; the same laboratory; the same treatment phase; and no biotin for 48 hours Al-Bahadili 2024.
What would have to change for the second result to mean something:
- Positive with a suppressed TSH? That combination is the diagnosis, and the numbers to follow are free T4 and free T3, not this one Xu 2023.
- Positive with a normal TSH? Ask about biotin and about heterophile interference before accepting it Al-Bahadili 2024.
- TRAb positive but the patient is hypothyroid? A binding assay cannot distinguish stimulating from blocking antibodies; a bioassay can, and that is the situation it exists for Yao 2024.
- Deciding whether to stop antithyroid drugs? A falling titer over 12 to 18 months is the prognostic signal; a single value is not Zhou 2021.
- Antibody negative but thyrotoxic? Check thyroglobulin-ab and thyroid-ab, and consider thyroiditis, which is antibody-negative for the TSH receptor.
What Thyroid-Stimulating Immunoglobulin (TSI) cannot tell you
A binding assay cannot tell you what the antibody does. Stimulating, blocking and neutral antibodies all bind Yao 2024.
It cannot measure thyroid function. A high titer with normal hormones is a person with antibodies, not a person with thyrotoxicosis — free T4 and free T3 measure the function.
It cannot be compared across assays, generations or units Lorde 2023 Xu 2023.
A negative result does not exclude Graves' disease, since sensitivity is high but not complete, and it is lowest early in the illness Xu 2023.
The wrong inference readers actually draw is that TSI and TRAb are the same test with two names. One measures receptor occupancy and the other measures receptor activation, they diverge exactly in the patients whose management depends on the answer, and no conversion factor exists between them Yao 2024 Leschik 2013.
Sources read for these sections
- Yao P, et al. Comparison between thyroid stimulating immunoglobulin and TSH-receptor antibodies in the diagnosis and management of Graves' disease. Frontiers in Endocrinology 2024 · PMID 39669491
- Xu S, et al. Evaluation of the diagnostic performance of thyroid-stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease. Journal of Clinical Laboratory Analysis 2023 · PMID 37161617
- Leschik JJ, et al. Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins. American Journal of Clinical Pathology 2013 · PMID 23355204
- Zhou Y, et al. The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves' disease. Therapeutic Advances in Endocrinology and Metabolism 2021 · PMID 34603682
- Al-Bahadili H, et al. The Complex Web of Interferences with Thyroid Function Tests. Endocrine Practice 2024 · PMID 39477092
- Lorde N, et al. Impact of Variation between Assays and Reference Intervals in the Diagnosis of Endocrine Disorders. Diagnostics (Basel) 2023 · PMID 37998589
Where to start with Thyroid-Stimulating Immunoglobulin (TSI)
In this order. Start at the supplement and you learn nothing, because you never established the number was real.
You have the range, where it came from and the first two moves. Inside is the rest of the five-pathway protocol — supplements, hormones, peptides — the order to run them in, and what to change when the number will not move.
Get the full protocol — $10/mo →📚 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism.
🩸 Test your Thyroid-Stimulating Immunoglobulin (TSI)
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 103 markers →What Thyroid-Stimulating Immunoglobulin (TSI) is usually tested alongside
One marker is a data point. These panels add the markers that make Thyroid-Stimulating Immunoglobulin (TSI) interpretable, name why each is on the list, and load the set into your cart at 10% off.
includes this + 8 more markers — Abnormal TSH, a goitre, a family history of thyroid disease, postpartum thyroid changes, or thyroid symptoms with 'normal' basic labs.
What people use Thyroid-Stimulating Immunoglobulin (TSI) to decide
Nobody orders a test for its own sake. Thyroid-Stimulating Immunoglobulin (TSI) is on the test list for these pathways — each one links to what the pathway claims, and what its test list is read for before you spend anything on it.
Antibodies appear years before symptoms do. Thyroid antibodies in particular are worth knowing with a normal TSH, because they change how you'd approach iodine and selenium entirely.
TSH alone is not a thyroid panel. Normal TSH with low free T3 is impaired conversion, and it is the single most common thing missed in fatigue — you need the full set to see it.
Would you feel it? Symptoms Thyroid-Stimulating Immunoglobulin (TSI) helps explain
People search for how they feel, not for a marker. These are the complaints where this one is worth checking, and whether it is first-line or a follow-up.
Why your Thyroid-Stimulating Immunoglobulin (TSI) might be wrong
Most abnormal results are interference, not disease. Check these before you change anything. Each says whether the number is wrong (repeat it), badly timed (redraw it), or real with a cause.
Biotin interferes with the streptavidin-biotin immunoassays most hormone tests run on. Depending on the assay design it pushes the result falsely HIGH or falsely LOW — there is no single direction to correct for. Hair, skin and nail products are the usual source, and doses in those are far above the RDA.
Stop biotin 48–72 hours before the draw, and check every supplement label rather than just the one labeled biotin.
Treatment changes titres over months, so a value only means something alongside where you are in treatment.
Note treatment status and dates on the result.
What Thyroid-Stimulating Immunoglobulin (TSI) means in combination
One marker tells you a little; combinations tell you the story. These are the named patterns this one takes part in.
Thyroid stimulating immunoglobulin is what distinguishes Graves' disease from the destructive thyroiditis that produces an identical early picture. The distinction decides the treatment: Graves' is overproduction and responds to antithyroid drugs, thyroiditis is leakage and does not.
A doctor's call. Postpartum, the timing also matters — the hyperthyroid phase of postpartum thyroiditis is TSI-negative and resolves on its own.
What to test next
These put Thyroid-Stimulating Immunoglobulin (TSI) in context — each with its own full breakdown.
Frequently asked questions
<140% baseline activity (assay dependent). Ranges vary by laboratory and assay — always compare to the range printed on your own report.
Negative. Interpretation is categorical; see the result-category block on this page.
Confirms Graves'. Associated with eye involvement (thyroid eye disease), particularly in smokers.
Negative — points toward other causes of hyperthyroidism.
You can order Thyroid-Stimulating Immunoglobulin (TSI) directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.
Where this goes next
This page is the free framework. The protocol itself — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.